Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. European Commission–AstraZeneca COVID-19 vaccine dispute

   en.wikipedia.org/wiki/European_Commission...

   A packet of AstraZeneca COVID-19 vaccine vials. A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, [ 1] and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol. [ 2][ 3][ 4 ...

3. Oxford–AstraZeneca COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID...

   The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. [ 1 ] The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).

4. AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/AstraZeneca

   AstraZeneca plc ( / ˌæstrəˈzɛnəkə /) ( AZ) is a British-Swedish multinational pharmaceutical and biotechnology company [ 2 ][ 3 ][ 4 ] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. [ 5 ] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal ...

5. AstraZeneca buys respiratory vaccine developer Icosavax in $1 ...

   www.aol.com/news/astrazeneca-buy-rsv-vaccine...

   AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion. Icosavax is developing a combination vaccine ...

6. U.S. trial determines Oxford COVID-19 vaccine is safe - AOL

   www.aol.com/news/astrazeneca-oxford-covid-19...

   AstraZeneca's COVID-19 vaccine developed with Oxford University was 79% effective in preventing symptomatic illness in a large trial in Chile, Peru and the United States, the company said on ...

7. AstraZeneca withdraws Covid-19 vaccine, citing low demand - AOL

   www.aol.com/astrazeneca-withdraws-covid-19...

   AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. AstraZeneca withdraws Covid-19 vaccine ...

8. COVID-19 vaccination in the United Kingdom - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in...

   Target. Immunisation of the public in the United Kingdom against COVID-19. Participants. 53,710,109 have received one vaccine dose. 50,483,527 have received two vaccine doses. 40,196,024 have received three vaccine doses, 6,200,537 have received a fourth dose [ 1] Outcome. 92.9% of UK population 12+ have received one vaccine dose.

9. AstraZeneca becomes first international company to file ... - AOL

   www.aol.com/finance/astrazeneca-becomes-first...

   AstraZeneca has joined the legal fight against Medicare drug pricing negotiations, becoming the sixth pharmaceutical company, and first international company, to file suit against US Health ...